Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues.  For people with autoimmune disease, T cell reactivity is a big ...

ENERGI-F705PD is a first-in-class, oral sustained-release therapy in development for Parkinson's disease, designed to address the underlying pathogenesis. Topline data from the Phase I trial in ...

This article reviews the PINK1 protein product, which has been implicated in several functions, mostly aimed at protecting neuronal cells against different types of stress.

Discover how scientists imaged the Parkinson’s protein PINK1, unlocking insight into its role in mitochondrial quality control and brain cell survival.

University of Dundee scientists have discovered a new target that could herald the development of new drugs to treat Parkinson’s disease.

1 of 3 | A new, simple blood test developed by Israeli researchers could allow Parkinson's disease sufferers to get an early warning before their motor symptoms manifest, by which time it is too ...

Study reveals the structure of PINK1 protein, offering fresh hope for Parkinson's patients through potential targeted therapies that address root causes.

Researchers have made a huge leap forward in the fight against Parkinson's disease, solving a decades-long mystery. In a major breakthrough, they have been able to see the human PINK1 protein ...

Researchers at the WEHI Parkinson’s Disease Research Centre have determined the first ever structure of human PINK1 bound to mitochondria, in findings published in Science.

PINK1 protein discovery could accelerate Parkinsons disease drug development New insights into mitochondria may pave the way for innovative treatments in neurodegenerative disorders.